Dan Ives, Wedbush Securities global head of technology research and senior equity analyst, joins 'Squawk Box' to discuss ...

Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to break down ...

Research analysts at Wedbush issued their FY2029 EPS estimates for shares of Arcus Biosciences in a note issued to investors ...

Research analysts at Wedbush cut their Q1 2025 earnings per share estimates for Wingstop in a research report issued to ...

Investing.com -- Tesla's stock has faced continued pressure in 2025, but Wedbush analysts remain bullish, maintaining their ...

If the Department of Defense goes through budget cuts as suggested by a leaked memo, Palantir Technologies (PLTR) would have ...

Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange ...

Avalo Therapeutics (AVTX) stock surges as Wedbush initiates with a bullish view, citing lead asset AVTX-009's potential against hidradenitis suppurativa. Read more here.

AI spending is ramping up, with Nvidia (NVDA) seeing strong Blackwell demand and IT budgets shifting toward AI investments ...

Analyst Dan Ives thinks Tesla stock could soar from current levels thanks to a potential $1 trillion catalyst.

The EV manufacturer earned a $110 million gross profit at its core automotive business in the fourth quarter, a milestone ...

Wedbush downgraded Jack in the Box (JACK) to Neutral from Outperform with a price target of $40, down from $50. While Jack in the Box’s ...